Medtronic announces acquisition of Medicrea
Click Here to Manage Email Alerts
Medtronic plc announced a tender offer agreement for the acquisition of Medicrea, according to a Medtronic press release.
Both companies have unanimously approved the transaction of all Medicrea’s outstanding shares at 22% over the closing price.
“Combining Medtronic’s innovative portfolio of spine implants, robotics, navigation and 3D imaging technology with Medicrea’s capabilities and solutions in data analytics, artificial intelligence and personalized implants, would enhance Medtronic’s fully integrated procedural solution for surgical planning and delivery,” Jacob Paul, senior vice president and president of Medtronic’s cranial and spinal technologies division, said in the release. “This marks another important step in furthering our commitment to improving outcomes in spine care,” he added.
“Spine surgery is one of the more complex procedures in health care because of the high number of different parameters to take into consideration. It is impossible for the human brain to compute all of them for one single patient,” Medicrea founder, chair and CEO Denys Sournac said in the release. “We are thrilled to be joining forces with Medtronic because we share a similar mission to restore the long-term quality of life for patients,” he added.